Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®

To investigate the effect of escalation of radiation dose to tumor and lymph nodes based on an inhomogeneous dose distribution controlled by FDG-PET positive areas compared to a standard homogeneous dose spread

Trial Details

NCT ID
NCT02354274
Phase
NA
Sponsor
Olfred Hansen
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Escalated: Inhomogeneous dose plan
  • Standard: Homogeneous dose plan
Locations (sample)
  • Aalborg, Denmark|57.048,9.9187
  • Aarhus, Denmark|56.15674,10.21076
  • Copenhagen, Denmark|55.67594,12.56553
  • Herlev, Denmark|55.72366,12.43998
  • Næstved, Denmark|55.22992,11.76092

Key Eligibility Criteria

  • Patients with histologically or cytologically proven locally advanced NSCLC stage IIB to IIIB
  • Performance status 0-1
  • Able to comply with treatment and follow study and follow-up procedures
  • Women must have negative pregnancy test

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →